000			02002 a2200565 4500
005			20250516075453.0
264		0	_c20130701
008			201307s 0 0 eng d
022			_a1468-3083
024	7		_a10.1111/j.1468-3083.2012.04450.x _2doi
040			_aNLM _beng _cNLM
100	1		_aGisondi, P
245	0	0	_aMetabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. _h[electronic resource]
260			_bJournal of the European Academy of Dermatology and Venereology : JEADV _cJan 2013
300			_ae30-41 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAge Distribution
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aCohort Studies
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aEvidence-Based Medicine
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aIncidence
650	0	4	_aItaly
650	0	4	_aMale
650	0	4	_aMetabolic Diseases _xchemically induced
650	0	4	_aProspective Studies
650	0	4	_aPsoriasis _xdiagnosis
650	0	4	_aRegistries
650	0	4	_aRisk Assessment
650	0	4	_aSeverity of Illness Index
650	0	4	_aSex Distribution
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aCazzaniga, S
700	1		_aChimenti, S
700	1		_aGiannetti, A
700	1		_aMaccarone, M
700	1		_aPicardo, M
700	1		_aGirolomoni, G
700	1		_aNaldi, L
773	0		_tJournal of the European Academy of Dermatology and Venereology : JEADV _gvol. 27 _gno. 1 _gp. e30-41
856	4	0	_uhttps://doi.org/10.1111/j.1468-3083.2012.04450.x _zAvailable from publisher's website
999			_c21525529 _d21525529